ArticleCell reports. Medicine2026

IND-enabling safety and efficacy of RPESC-RPE-4W, an adult RPE progenitor cell therapy for dry age-related macular degeneration.

Brigitte L Arduini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.